Scholars Central

Conference abstractPublished 29 May 2017

Efficacy and tolerability of the autoimmune protocol diet for inflammatory bowel disease

Authors: Gauree Gupta Konijeti, Crystal Sanchez, Caroline Diamant, Emily Singh, James Lewis, Namee Kim, Glenn Oliviera, Xiaoyun Wang, Bhuvan Molparia, Shauna Groven, Sirisha Grandhe, Ali Torkamani

Scripps Clinic, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Recent data suggests dietary modification can improve clinical responses in inflammatory bowel disease (IBD). The goal of this study was to determine the tolerability and efficacy of an autoimmune protocol (AIP) diet in patients with Crohn's disease (CD) and ulcerative colitis (UC). Methods: We enrolled 18 adult patients with IBD with mild-moderate disease activity (HBI âÂ?¥ 5 or partial Mayo score âÂ?¥ 3), and objective evidence of active disease (endoscopy within 7 months and/or elevated fecal calprotectin (FC) within 1 month). Three patients withdrew prior to study start due to inability to commit to dietary change. Participants transitioned to the AIP diet over 6 weeks (elimination of grains, legumes, nightshades, dairy, eggs, coffee, alcohol, nuts and seeds, and refined/processed sugars, oils, and food additives) and then maintained the diet for 5 additional weeks. Serial laboratories, fecal calprotectin, microbiome and transcriptome analyses were performed. Endoscopy, radiology, and/or biomarker assessment was performed at study completion to assess for mucosal healing. Results: The final cohort included 9 patients with CD and 6 with UC. Mean IBD duration was 19 years (SD 14.6) and active biologic use in 7 patients. Nutrient repletion was initiated for deficiencies in vitamin D (n=3) and iron (n=6). From week 0 to 6, mean partial Mayo score improved from 5.8 (SD 1.2) to 1.2 (SD 2.0) (p<0.01) for UC, and mean HBI score improved from 7 (SD 1.5) to 3.6 (SD 2.1) (p<0.01). At baseline, CRP was normal (<10) in 66% (10/15). Among those with labs completed at baseline and week 6, mean CRP (n=11) improved from 8.3 to 7.0 (p=0.46), and mean FC (n=5) improved from 412 (range 80-1078) to 196 (range 0-758) (p=0.36). Among those with follow-up endoscopy at week 11 (n=7), improvements were noted in SES-CD (n=1), Rutgeerts score (n=1), and Mayo endoscopy subscore (n=4). No significant changes in lipid profile observed at week 6. One patient with ileal CD with stricture withdrew due to worsening symptoms. Discussion: Dietary elimination has the potential to improve symptoms and endoscopic inflammation in patients with inflammatory bowel disease. Larger randomized trials are needed to validate these findings.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Nutrition & Food Sciences.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nutrition & Food Sciences
  • SubjectNutrition & Food Science
  • BylineArticles whose byline prints “Gauree Gupta Konijeti”
  • BylineArticles whose byline prints “Crystal Sanchez”
  • BylineArticles whose byline prints “Caroline Diamant”
  • BylineArticles whose byline prints “Emily Singh”
  • BylineArticles whose byline prints “James Lewis”
  • BylineArticles whose byline prints “Namee Kim”
  • BylineArticles whose byline prints “Glenn Oliviera”
  • BylineArticles whose byline prints “Xiaoyun Wang”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels